Pd. Hrdina et al., PLATELET SEROTONERGIC INDEXES IN MAJOR DEPRESSION - UP-REGULATION OF 5-HT2A RECEPTORS UNCHANGED BY ANTIDEPRESSANT TREATMENT, Psychiatry research, 66(2-3), 1997, pp. 73-85
This study examined, in the largest sample of major depressives report
ed so far, platelet serotonergic parameters (5-HT uptake, [H-3]paroxet
ine binding and 5-HT2A receptors measured by [H-3]LSD binding) in 60 a
ntidepressant-free depressed patients and 40 age- and gender-matched c
ontrol subject's before treatment, and in 45 major depression patients
during treatment with antidepressants. We found that, at baseline, th
e density (B-max) of 5-HT2A receptors was significantly higher (by 39%
) in depressed patients than in controls. Suicidal patients had signif
icantly higher B-max values than controls or non-suicidal patients. Th
e rate of serotonin uptake (V-max) but not the uptake at a single conc
entration, was significantly higher in depressed patients, particularl
y in females. There was no significant difference between the K-d or B
-max of [H-3]paroxetine binding in control and depressed subjects. Tre
atment with antidepressant drugs of different pharmacological profile
had no significant effect on the density of 5-HT2A receptors, nor did
the receptor number predict the response to treatment. The affinity of
serotonin uptake site for 5-HT and [H-3]paroxetine significantly decr
eased during treatment with antidepressants, particularly SSRIs. Suppr
ession of 5-HT uptake correlated with decreases in Hamilton depression
(HAMD) scores. Our data suggest that the increased density of platele
t 5-HT2A receptors may be associated with untreated major depression i
n antidepressant-free depressed patients, in particular those with sui
cidal thoughts. The persistence after antidepressant treatment and cli
nical improvement would suggest that up-regulation of 5-HT2A receptors
is a trait rather than state phenomenon. Correlation of 5-HT2A uptake
suppression with decreases in HAMD scores suggests that serotonin upt
ake inhibition is a relevant factor in antidepressant drug effect and
clinical improvement. (C) 1997 Elsevier Science Ireland Ltd.